Last updated on July 2019

A Study to Evaluate Safety Efficacy Pharmacokinetics and Pharmacodynamics of Leuprolide Acetate 45mg 6-Month Formulation in Children With Central Precocious Puberty (CPP)


Brief description of study

The primary objective of the study is to assess the safety and efficacy of a leuprolide acetate (LA) 45 mg 6-month depot formulation for the treatment of CPP in children who are either nave to treatment with a gonadotropin-releasing hormone agonist (GnRHa) or who have been previously treated with a GnRHa.

Clinical Study Identifier: NCT03695237

Find a site near you

Start Over